Assisted Reproductive Technology Survey (ART Survey)

Female Reproductive Problem Clinical Trial

— ART  

Official title:

ART Survey: Assisted Reproductive Technology Survey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02249390
• Other study ID #: PBRC 2014-042
• Status: Completed
• Start date: September 2014
• Est. completion date: April 2017

Study information

• Verified date: September 2022
• Source: Pennington Biomedical Research Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to collate local information to better understand the motivations, accessibility and frequency of assisted reproductive technology (ART) use in the community.

Description:

The ART survey study recruitment will last about 6 months with the study completed within 1 year. Study participation is an online survey which takes approximately 3 minutes to complete.

The goal is to apply for future funding to study the metabolic consequences of being conceived with ART.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 336
• Est. completion date: April 2017
• Est. primary completion date: April 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Any individual may complete this survey

Exclusion Criteria:

• No exclusion criteria

Related Conditions & MeSH terms

• Female Reproductive Problem
• Male Reproductive Problem

Locations

Country	Name	City	State
United States	Pennington Biomedical Research Center	Baton Rouge	Louisiana

Sponsors (1)

Lead Sponsor	Collaborator
Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Method of Conception	ART Survey	1 year